BVAXF
Price:
$0.04605
Market Cap:
$16.64M
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research c...[Read more]
Industry
Biotechnology
IPO Date
2018-12-28
Stock Exchange
PNK
Ticker
BVAXF
According to BioVaxys Technology Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -2.30. This represents a change of 30.05% compared to the average of -1.77 of the last 4 quarters.
The mean historical PE Ratio of BioVaxys Technology Corp. over the last ten years is -5.44. The current -2.30 PE Ratio has changed 4.13% with respect to the historical average. Over the past ten years (40 quarters), BVAXF's PE Ratio was at its highest in in the January 2024 quarter at 3.15. The PE Ratio was at its lowest in in the April 2020 quarter at -22.16.
Average
-5.44
Median
-2.89
Minimum
-20.11
Maximum
0
Discovering the peaks and valleys of BioVaxys Technology Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 218.54%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -20.11
Year | PE Ratio | Change |
---|---|---|
2023 | -0.44 | -58.04% |
2022 | -1.04 | -78.06% |
2021 | -4.74 | -76.43% |
2020 | -20.11 | 218.54% |
2019 | -6.31 | -Infinity% |
The current PE Ratio of BioVaxys Technology Corp. (BVAXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.07
5-year avg
-6.53
10-year avg
-5.44
BioVaxys Technology Corp.’s PE Ratio is greater than Biotron Limited (-4.46), less than Bioasis Technologies Inc. (0), greater than Covalon Technologies Ltd. (-98.57), greater than Mosaic ImmunoEngineering Inc. (-16.17), greater than Ceapro Inc. (-2.83), less than Cellectis S.A. (-1.62), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (-0.47), less than Small Pharma Inc. (0), less than TRACON Pharmaceuticals, Inc. (-2.26), less than Wesana Health Holdings Inc. (0.02), less than GH Research PLC (-0.30), greater than Algernon Pharmaceuticals Inc. (-8.90), less than AXIM Biotechnologies, Inc. (-0.95), less than null (-0.14),
Company | PE Ratio | Market cap |
---|---|---|
-4.46 | $9.11M | |
0 | $27.62M | |
-98.57 | $62.47M | |
-16.17 | $5.08M | |
-2.83 | $13.31M | |
-1.62 | $183.12M | |
-0.47 | $0 | |
0 | $37.51M | |
-2.26 | $109.72K | |
0.02 | $206.34K | |
-0.30 | $368.88M | |
-8.90 | $964.52K | |
-0.95 | $603.92K | |
-0.14 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVaxys Technology Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioVaxys Technology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioVaxys Technology Corp.'s PE Ratio?
How is the PE Ratio calculated for BioVaxys Technology Corp. (BVAXF)?
What is the highest PE Ratio for BioVaxys Technology Corp. (BVAXF)?
What is the 3-year average PE Ratio for BioVaxys Technology Corp. (BVAXF)?
What is the 5-year average PE Ratio for BioVaxys Technology Corp. (BVAXF)?
How does the current PE Ratio for BioVaxys Technology Corp. (BVAXF) compare to its historical average?